CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.187
https://www.valueinhealthjournal.com/article/S1098-3015(23)00287-5/fulltext
Title :
CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00287-5&doi=10.1016/j.jval.2023.03.187
First page :
Section Title :
Open access? :
No
Section Order :
11345